TY - JOUR
TI - Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy
AU - Pappa, V.
AU - Girkas, K.
AU - Sambani, C.
AU - Pagageorgiou, S.
AU - Tsirigiotis, P.
AU - Karvounis, K.
AU - Stathopoulou, E.
AU - Economopoulos, T.
AU - Dimitriadis, G.
AU - Dervenoulas, I.
JO - Leukemia Research
PY - 2012
VL - 36
TODO - 4
SP - e78-e80
PB - 
SN - 0145-2126
TODO - 10.1016/j.leukres.2011.11.022
TODO - azacitidine;  hemoglobin, acute granulocytic leukemia;  aged;  blood toxicity;  bone marrow biopsy;  cancer patient;  case report;  Caucasian;  cytogenetics;  erythrocyte transfusion;  female;  hemoglobin blood level;  human;  injection site reaction;  karyotype 46,XX;  karyotyping;  laboratory test;  letter;  leukocyte count;  long term care;  multiple cycle treatment;  myelodysplastic syndrome;  neutrophil count;  patient referral;  priority journal;  thrombocyte count;  treatment outcome, Abnormal Karyotype;  Aged;  Antimetabolites, Antineoplastic;  Azacitidine;  Female;  Follow-Up Studies;  Humans;  Leukemia, Myeloid, Acute;  Randomized Controlled Trials as Topic;  Risk;  Treatment Outcome
TODO - null
ER -